Aruna Kamineni, PhD

“I'm working on reducing cancer through better screening. I collaborate with researchers nationwide on studies that will make screening more effective, patient-friendly, and personalized.”

Aruna  Kamineni, PhD

Assistant Investigator, Kaiser Permanente Washington Health Research Institute


Aruna Kamineni, PhD, came to Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in cardiovascular and cancer epidemiology. After 9 successful years as a research associate, she was promoted to assistant investigator in 2018. She is currently working with Senior Investigator Diana Buist, PhD, and others to compare the effectiveness of  various screening strategies for cervical and colorectal cancers. Dr. Kamineni’s future research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and  screening programs.

Research interests and experience

Recent publications

Doria-Rose VP, Kamineni A, Barrett MJ, Ko CW, Weiss NS. Case-control studies of the efficacy of screening tests that seek to prevent cancer incidence: results of an approach that utilizes administrative claims data that do not provide information regarding test indication. Am J Epidemiol. 2019 Jan 29. doi: 10.1093/aje/kwy274. [Epub ahead of print]. PubMed

Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of colonoscopy following diagnosis of advanced adenomas: an analysis within integrated healthcare delivery systems. lid - 10.1158/1055-9965.epi-18-0452 [doi] Cancer Epidemiol Biomarkers Prev. 2018 Nov 20. pii: 1055-9965.EPI-18-0452. doi: 10.1158/1055-9965.EPI-18-0452 [Epub ahead of print] PubMed

Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Doria-Rose VP. Cervical cancer screening research in the PROSPR I Consortium: rationale, methods, and baseline findings from a U.S. cohort. Int J Cancer. 2018 Oct 24. doi: 10.1002/ijc.31940. [Epub ahead of print]. PubMed

Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018;169(7):439-447. doi: 10.7326/M18-0244. Epub 2018 Sep 18. PubMed


innovating care

How to maximize screening for colon cancer

Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.

Read about it in News and Events.

Cancer Research

Research funded to improve cancer screening

Drs. Kamineni and Chubak are among leaders of 2 new large PROSPR awards from NCI for cervical and colorectal cancer screening research.

Read it in News and Events

News release

Colon cancer screening doubles with new e-health record use

featured video


Making Medicine Better by Working Together

(YouTube, 5:33)